Top Stocks for Investment The January 17th Top Stock Picks on Zacks Rank #1 List

Photo of author

By Ronald Tech

Revealed, listed below are the latest additions to Zacks Rank #1 (Strong Buy) List:

Skyward Specialty Insurance Group, Inc. SKWD: A robust contender in the insurance sector, specializing in underwriting commercial property and casualty insurance primarily in the United States. This company has experienced a remarkable surge in its Zacks Consensus Estimate for current-year earnings, escalating by a notable 6.7% over the past 60 days.

Performance Review of Skyward Specialty Insurance Group, Inc.

Skyward Specialty Insurance Group, Inc. Performance Review

Skyward Specialty Insurance Group, Inc. price-consensus-chart | Skyward Specialty Insurance Group, Inc. Quote

Koninklijke Philips PHG: This technology giant specializing in health diagnostics & treatment businesses, connected care businesses, and personal health businesses segments has seen a solid 4.7% increase in the Zacks Consensus Estimate for its current-year earnings over the past 60 days.

Koninklijke Philips N.V. Performance Review

Performance Review of Koninklijke Philips N.V.

Koninklijke Philips N.V. price-consensus-chart | Koninklijke Philips N.V. Quote

The Bank of New York Mellon BK: A prominent player in the financial services arena, operating across 35 countries and offering an array of products and services to individuals and institutions. The company has witnessed a 2.2% surge in the Zacks Consensus Estimate for its current-year earnings in the last 60 days.

The Bank of New York Mellon Corporation Performance Review

Performance Review of The Bank of New York Mellon Corporation

The Bank of New York Mellon Corporation price-consensus-chart | The Bank of New York Mellon Corporation Quote

PagSeguro Digital PAGS: A global player providing financial technology solutions and services catering to micro-merchants and small and medium-sized businesses, primarily in Brazil and on an international scale. The company has observed a 2.0% uptick in the Zacks Consensus Estimate for its current-year earnings over the previous 60 days.

See also  Unearthing Hidden Gems: AI Stocks Poised for Growth

PagSeguro Digital Ltd. Performance Review

Performance Review of PagSeguro Digital Ltd.

PagSeguro Digital Ltd. price-consensus-chart | PagSeguro Digital Ltd. Quote

Genmab GMAB: A leading biotechnology company specializing in the development of antibody therapeutics for cancer treatment. The company has witnessed a 1.7% increase in the Zacks Consensus Estimate for its current-year earnings over the last 60 days.

Genmab A/S Sponsored ADR Performance Review

Performance Review of Genmab A/S Sponsored ADR

Genmab A/S Sponsored ADR price-consensus-chart | Genmab A/S Sponsored ADR Quote

Keep a lookout for the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Only $1 to See All Zacks’ Buys and Sells

Surprising but true. A few years back, Zacks astonished many by offering a 30-day privilege of accessing all their picks for a negligible sum of $1. No obligations beyond that. Thousands have embraced this opportunity, while thousands remained skeptical, unable to believe such a deal existed without a catch. The motivation behind this offering is to introduce investors to Zacks’ portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, which have already closed a remarkable 162 positions with double- and triple-digit gains in 2023 alone.

Discover Stocks Now >>

Interested in the latest recommendations from Zacks Investment Research? You can download 7 Best Stocks for the Next 30 Days. Click to get this free report now

Zacks Investment Research